272 related articles for article (PubMed ID: 28291243)
1. A standard database for drug repositioning.
Brown AS; Patel CJ
Sci Data; 2017 Mar; 4():170029. PubMed ID: 28291243
[TBL] [Abstract][Full Text] [Related]
2. Non-Negative Matrix Factorization for Drug Repositioning: Experiments with the repoDB Dataset.
Bakal G; Kilicoglu H; Kavuluru R
AMIA Annu Symp Proc; 2019; 2019():238-247. PubMed ID: 32308816
[TBL] [Abstract][Full Text] [Related]
3. A review of validation strategies for computational drug repositioning.
Brown AS; Patel CJ
Brief Bioinform; 2018 Jan; 19(1):174-177. PubMed ID: 27881429
[TBL] [Abstract][Full Text] [Related]
4. MeSHDD: Literature-based drug-drug similarity for drug repositioning.
Brown AS; Patel CJ
J Am Med Inform Assoc; 2017 May; 24(3):614-618. PubMed ID: 27678460
[TBL] [Abstract][Full Text] [Related]
5. DMAP: a connectivity map database to enable identification of novel drug repositioning candidates.
Huang H; Nguyen T; Ibrahim S; Shantharam S; Yue Z; Chen JY
BMC Bioinformatics; 2015; 16 Suppl 13(Suppl 13):S4. PubMed ID: 26423722
[TBL] [Abstract][Full Text] [Related]
6. DrugNet: network-based drug-disease prioritization by integrating heterogeneous data.
Martínez V; Navarro C; Cano C; Fajardo W; Blanco A
Artif Intell Med; 2015 Jan; 63(1):41-9. PubMed ID: 25704113
[TBL] [Abstract][Full Text] [Related]
7. Implementation of a Pipeline Using Disease-Disease Associations for Computational Drug Repurposing.
Balasundaram P; Kanagavelu R; James N; Maiti S; Veerappapillai S; Karuppaswamy R
Methods Mol Biol; 2019; 1903():129-148. PubMed ID: 30547440
[TBL] [Abstract][Full Text] [Related]
8. Molecular Topology and Other Promiscuity Determinants as Predictors of Therapeutic Class - A Theoretical Framework to Guide Drug Repositioning?
Morales JF; Alberca LN; Chuguransky S; Di Ianni ME; Talevi A; Ruiz ME
Curr Top Med Chem; 2018; 18(13):1110-1122. PubMed ID: 30068278
[TBL] [Abstract][Full Text] [Related]
9. ksRepo: a generalized platform for computational drug repositioning.
Brown AS; Kong SW; Kohane IS; Patel CJ
BMC Bioinformatics; 2016 Feb; 17():78. PubMed ID: 26860211
[TBL] [Abstract][Full Text] [Related]
10. Prediction of drug indications based on chemical interactions and chemical similarities.
Huang G; Lu Y; Lu C; Zheng M; Cai YD
Biomed Res Int; 2015; 2015():584546. PubMed ID: 25821813
[TBL] [Abstract][Full Text] [Related]
11. A Review of Recent Developments and Progress in Computational Drug Repositioning.
Shi W; Chen X; Deng L
Curr Pharm Des; 2020; 26(26):3059-3068. PubMed ID: 31951162
[TBL] [Abstract][Full Text] [Related]
12. Time-resolved evaluation of compound repositioning predictions on a text-mined knowledge network.
Mayers M; Li TS; Queralt-Rosinach N; Su AI
BMC Bioinformatics; 2019 Dec; 20(1):653. PubMed ID: 31829175
[TBL] [Abstract][Full Text] [Related]
13. Transcriptomic-Guided Drug Repositioning Supported by a New Bioinformatics Search Tool: geneXpharma.
Turanli B; Gulfidan G; Arga KY
OMICS; 2017 Oct; 21(10):584-591. PubMed ID: 29049014
[TBL] [Abstract][Full Text] [Related]
14. Disease comorbidity-guided drug repositioning: a case study in schizophrenia.
Wang Q; Xu R
AMIA Annu Symp Proc; 2018; 2018():1300-1309. PubMed ID: 30815174
[TBL] [Abstract][Full Text] [Related]
15. A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.
Chen H; Zhang Z
Biomed Res Int; 2015; 2015():406463. PubMed ID: 25789319
[TBL] [Abstract][Full Text] [Related]
16. In silico drug repositioning: what we need to know.
Liu Z; Fang H; Reagan K; Xu X; Mendrick DL; Slikker W; Tong W
Drug Discov Today; 2013 Feb; 18(3-4):110-5. PubMed ID: 22935104
[TBL] [Abstract][Full Text] [Related]
17. Realizing drug repositioning by adapting a recommendation system to handle the process.
Ozsoy MG; Özyer T; Polat F; Alhajj R
BMC Bioinformatics; 2018 Apr; 19(1):136. PubMed ID: 29649971
[TBL] [Abstract][Full Text] [Related]
18. RepCOOL: computational drug repositioning via integrating heterogeneous biological networks.
Fahimian G; Zahiri J; Arab SS; Sajedi RH
J Transl Med; 2020 Oct; 18(1):375. PubMed ID: 33008415
[TBL] [Abstract][Full Text] [Related]
19. Drug repositioning for enzyme modulator based on human metabolite-likeness.
Lee YH; Choi H; Park S; Lee B; Yi GS
BMC Bioinformatics; 2017 May; 18(Suppl 7):226. PubMed ID: 28617219
[TBL] [Abstract][Full Text] [Related]
20. Drug Repositioning: A Unique Approach to Refurbish Drug Discovery.
Kale MA; Shamkuwar PB; Mourya VK; Deshpande AB; Shelke PA
Curr Drug Discov Technol; 2022; 19(1):e140122192307. PubMed ID: 33726652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
